These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 12097545)
21. [Pharmacodynamic assessment of antibiotic sensitivity of Streptococcus pneumoniae]. Soriano F Med Clin (Barc); 1999 Jun; 113(3):103-8. PubMed ID: 10464745 [No Abstract] [Full Text] [Related]
22. [Pneumococcus and quinolone resistance]. Bello S; Torres A Arch Bronconeumol; 2003 Mar; 39(3):97-100. PubMed ID: 12622966 [No Abstract] [Full Text] [Related]
23. Levofloxacin treatment failure in a patient with fluoroquinolone-resistant Streptococcus pneumoniae pneumonia. Kays MB; Smith DW; Wack ME; Denys GA Pharmacotherapy; 2002 Mar; 22(3):395-9. PubMed ID: 11898897 [TBL] [Abstract][Full Text] [Related]
24. Attacking the pneumococcus -- a hundred years' war. Swartz MN N Engl J Med; 2002 Mar; 346(10):722. PubMed ID: 11882726 [No Abstract] [Full Text] [Related]
25. Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin. Kelley MA; Weber DJ; Gilligan P; Cohen MS Clin Infect Dis; 2000 Oct; 31(4):1008-11. PubMed ID: 11049784 [TBL] [Abstract][Full Text] [Related]
26. High level of resistance to levofloxacin of Streptococcus pneumoniae following fluoroquinolone therapy. d'Escrivan T; Roussel-Delvallez M; Alfandari S; Guery B Infection; 2003 Oct; 31(5):366. PubMed ID: 14556066 [No Abstract] [Full Text] [Related]
27. Bacteremia and meningitis caused by a macrolide-sensitive strain of Streptococcus pneumoniae during treatment with azithromycin. Lisby G; Brasholt MS; Teglbjerg MS Clin Infect Dis; 2001 Aug; 33(3):415-6. PubMed ID: 11438918 [No Abstract] [Full Text] [Related]
34. Antibiotic resistance in Streptococcus pneumoniae: what does the future hold? Nuermberger EL; Bishai WR Clin Infect Dis; 2004 May; 38 Suppl 4():S363-71. PubMed ID: 15127371 [TBL] [Abstract][Full Text] [Related]
35. In vitro activity of ertapenem against bacteraemic pneumococci: report of a French multicentre study including 339 strains. Decousser JW; Methlouthi I; Pina P; Allouch P; J Antimicrob Chemother; 2005 Mar; 55(3):396-8. PubMed ID: 15705639 [No Abstract] [Full Text] [Related]
37. In vitro activity of quinolones against S. pneumoniae, H. influenzae and M. catarrhalis in Saudi Arabia. Balkhy HH; Memish ZA; Shibl A; Elbashier A; Osoba A East Mediterr Health J; 2005; 11(1-2):36-44. PubMed ID: 16532669 [TBL] [Abstract][Full Text] [Related]
38. In vivo veritas: in vitro macrolide resistance in systemic Streptococcus pneumoniae infections does result in clinical failure. Jacobs MR Clin Infect Dis; 2002 Sep; 35(5):565-9. PubMed ID: 12173130 [No Abstract] [Full Text] [Related]
39. A review of clinical failures associated with macrolide-resistant Streptococcus pneumoniae. Rzeszutek M; Wierzbowski A; Hoban DJ; Conly J; Bishai W; Zhanel GG Int J Antimicrob Agents; 2004 Aug; 24(2):95-104. PubMed ID: 15288306 [TBL] [Abstract][Full Text] [Related]
40. [Various prospective approaches to the treatment of nonspecific lung diseases]. Sil'vestrov VP; Vanina NF Ter Arkh; 1980; 52(3):3-12. PubMed ID: 6966837 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]